EP3634385A4 - Methods for the preparation of liposomes comprising drugs - Google Patents
Methods for the preparation of liposomes comprising drugs Download PDFInfo
- Publication number
- EP3634385A4 EP3634385A4 EP18799204.5A EP18799204A EP3634385A4 EP 3634385 A4 EP3634385 A4 EP 3634385A4 EP 18799204 A EP18799204 A EP 18799204A EP 3634385 A4 EP3634385 A4 EP 3634385A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- liposomes
- drugs
- preparation
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/593,586 US20170340563A1 (en) | 2009-09-23 | 2017-05-12 | Methods for the Preparation of Liposomes Comprising Drugs |
PCT/US2018/032541 WO2018209342A1 (en) | 2017-05-12 | 2018-05-14 | Methods for the preparation of liposomes comprising drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3634385A1 EP3634385A1 (en) | 2020-04-15 |
EP3634385A4 true EP3634385A4 (en) | 2021-03-03 |
Family
ID=64105643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18799204.5A Pending EP3634385A4 (en) | 2017-05-12 | 2018-05-14 | Methods for the preparation of liposomes comprising drugs |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3634385A4 (en) |
JP (1) | JP2020519699A (en) |
CN (1) | CN110869006A (en) |
CA (1) | CA3063395A1 (en) |
WO (1) | WO2018209342A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113406957B (en) * | 2021-05-19 | 2022-07-08 | 成都理工大学 | Mobile robot autonomous navigation method based on immune deep reinforcement learning |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5683714A (en) * | 1991-04-19 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Liposomal cyclosporin pharmaceutical formulation |
US20040126886A1 (en) * | 2000-09-25 | 2004-07-01 | Industrial Technology Research Institute | Liposome for incorporating large amounts of hydrophobic substances |
US20110070292A1 (en) * | 2009-09-23 | 2011-03-24 | Javeri Indu | Methods For The Preparation Of Liposomes |
EA022182B1 (en) * | 2012-12-24 | 2015-11-30 | Общество С Ограниченной Ответственностью "Технология Лекарств" | Method of producing docetaxel liposome form |
WO2016134066A1 (en) * | 2015-02-17 | 2016-08-25 | Mallinckrodt Llc | Modified docetaxel liposome formulations and uses thereof |
US20160361259A1 (en) * | 2009-09-23 | 2016-12-15 | Indu JAVERI | Methods for the Preparation of Liposomes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4906476A (en) * | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
AU2002312777B2 (en) * | 2001-03-27 | 2007-07-05 | Phares Pharmaceutical Research N.V. | Method and composition for solubilising a biologically active compound with low water solubility |
JP2006248978A (en) * | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | New liposome preparation |
CN101244039B (en) * | 2008-03-20 | 2012-09-12 | 江苏先声药物研究有限公司 | Novel method for preparing indissoluble medicaments liposome preparations |
CN101744767B (en) * | 2008-12-05 | 2013-02-13 | 中国人民解放军军事医学科学院毒物药物研究所 | Thermal sensitive liposome preparation containing camptothecin antineoplastic agents |
US20110070294A1 (en) * | 2009-09-23 | 2011-03-24 | Javeri Indu | Methods for the Administration of Drugs Using Liposomes |
US20170340563A1 (en) * | 2009-09-23 | 2017-11-30 | Curirx Inc. | Methods for the Preparation of Liposomes Comprising Drugs |
CN103622911B (en) * | 2013-11-19 | 2015-12-30 | 常州金远药业制造有限公司 | A kind of hard-soluble medicine liposome preparation method |
-
2018
- 2018-05-14 CN CN201880045735.2A patent/CN110869006A/en active Pending
- 2018-05-14 EP EP18799204.5A patent/EP3634385A4/en active Pending
- 2018-05-14 WO PCT/US2018/032541 patent/WO2018209342A1/en active Application Filing
- 2018-05-14 JP JP2020513490A patent/JP2020519699A/en active Pending
- 2018-05-14 CA CA3063395A patent/CA3063395A1/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5683714A (en) * | 1991-04-19 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Liposomal cyclosporin pharmaceutical formulation |
US20040126886A1 (en) * | 2000-09-25 | 2004-07-01 | Industrial Technology Research Institute | Liposome for incorporating large amounts of hydrophobic substances |
US20110070292A1 (en) * | 2009-09-23 | 2011-03-24 | Javeri Indu | Methods For The Preparation Of Liposomes |
US20160361259A1 (en) * | 2009-09-23 | 2016-12-15 | Indu JAVERI | Methods for the Preparation of Liposomes |
EA022182B1 (en) * | 2012-12-24 | 2015-11-30 | Общество С Ограниченной Ответственностью "Технология Лекарств" | Method of producing docetaxel liposome form |
WO2016134066A1 (en) * | 2015-02-17 | 2016-08-25 | Mallinckrodt Llc | Modified docetaxel liposome formulations and uses thereof |
Non-Patent Citations (1)
Title |
---|
See also references of WO2018209342A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA3063395A1 (en) | 2018-11-15 |
CN110869006A (en) | 2020-03-06 |
EP3634385A1 (en) | 2020-04-15 |
WO2018209342A1 (en) | 2018-11-15 |
JP2020519699A (en) | 2020-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3582784A4 (en) | Processes for the preparation of benzodiazepine derivatives | |
EP3468973A4 (en) | Solid forms of venetoclax and processes for the preparation of venetoclax | |
EP3302436A4 (en) | Liposomal nanoconstructs and methods of making and using the same | |
EP3096763A4 (en) | Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof | |
EP3603642A4 (en) | Pharmaceutical preparation | |
EP3370728A4 (en) | Methods for the preparation of obeticholic acid and derivatives thereof | |
EP3344325A4 (en) | Local administration of drugs for the treatment of asthma | |
EP3297678A4 (en) | An improved processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof | |
EP3438105A4 (en) | Diaryl- -lactam compound and preparation method and pharmaceutical use thereof | |
EP3280408A4 (en) | Process for the preparation of dicycloplatin | |
EP3399996A4 (en) | Methods of administering hepcidin | |
EP3590514A4 (en) | Medicinal preparation | |
EP3454847A4 (en) | Improved drug formulations | |
EP3265059A4 (en) | Combination liposomal pharmaceutical formulations | |
EP3694499A4 (en) | Novel process for the preparation of lifitegrast | |
EP3528787A4 (en) | Pharmaceutical formulations and methods of making the same | |
EP3445358A4 (en) | Administration of berberine metabolites | |
EP3646866A4 (en) | Pharmaceutical preparation | |
EP3728241A4 (en) | Process for the preparation of opicapone and intermediates thereof | |
EP3718537A4 (en) | Disease-site-specific liposomal formulation | |
EP3445370A4 (en) | Methods for the preparation of obeticholic acid and derivatives thereof | |
EP3347380A4 (en) | Enhanced delivery of drugs to the brain | |
EP3519382A4 (en) | An improved process for the preparation of lacosamide | |
EP3424509A4 (en) | Liquid medicinal preparation | |
EP3319980B8 (en) | Formulations for improving the efficacy of hydrophobic drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20191210 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40028247 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210129 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 38/00 20060101ALI20210125BHEP Ipc: A61K 31/337 20060101ALI20210125BHEP Ipc: A61K 9/127 20060101AFI20210125BHEP Ipc: A61K 39/00 20060101ALI20210125BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20220909 |